Astellas Pharma
NeswBlaze top writers
Connections
Around the web
-
Medivation and Astellas Announce Initiation of Expanded Access Program for Enzalutamide (formerly MDV3100) in the United States
SAN FRANCISCO, CA and TOKYO--(Marketwire - May 30, 2012) - Medivation, Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. (Tokyo: 4503) announced that the U.S. Food and Drug Administration (FDA) agreed that Medivation and Astellas may proceed with an Expanded 10:09 AM from MarketWire Read more »
-
Medivation and Astellas Announce Initiation of Expanded Access Program for Enzalutamide (formerly MDV3100) in the United States
SAN FRANCISCO, CA and TOKYO -- (Marketwire) -- 05/30/12 -- Medivation, Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. (Tokyo: 4503) announced that the U.S. Food and Drug Administration (FDA) agreed that Medivation and Astellas may proceed with an Expanded 7:19 AM from iStockAnalyst Read more »
-
Medivation, (MDVN), Astellas Pharma to Proceed with EAP for Enzalutamide
Medivation, Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. (Tokyo: 4503) announced that the U.S. Food and Drug Administration (FDA) agreed that Medivation and Astellas may proceed with an Expanded Access Program (EAP) for the investigational therapy enzalu 7:06 AM from Street Insider Read more »
-
Astellas, Huawei, Formula One: Intellectual Property
A unit of Japan’s Astellas Pharma Inc. (4503) sued Hospira Inc. (HSP), accusing the generic pharmaceutical company of infringing a patent for the drug adenosine, used to diagnose heart blockages. Astellas contends Lake Forest, Illinois-based Hospira is p from Bloomberg.com Read more »
-
Astellas Pharma Sues Hospira Over Patent for Heart-Test Drug
A unit of Japan’s Astellas Pharma Inc. (4503) sued Hospira Inc. (HSP), accusing the generic pharmaceutical company of infringing a patent for the drug adenosine, used to diagnose heart blockages. Astellas contends Lake Forest, Illinois-based Hospira is p from Bloomberg.com Read more »
